These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37522989)

  • 1. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.
    Motoyama H; Kobayashi A; Yokoyama T; Shimizu A; Kitagawa N; Notake T; Fukushima K; Masuo H; Yoshizawa T; Miyagawa SI
    World J Surg; 2017 Nov; 41(11):2817-2829. PubMed ID: 28717913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
    Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
    Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of peritoneal washing cytology in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Baba K; Harada T; Serikawa M; Ishii Y; Nakamura S; Arihiro K; Murakami Y; Takahashi S
    Langenbecks Arch Surg; 2024 Jan; 409(1):45. PubMed ID: 38252293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
    Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
    HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
    Morino K; Seo S; Yoh T; Fukumitsu K; Ishii T; Taura K; Morita S; Kaido T; Uemoto S
    Ann Surg Oncol; 2020 Jun; 27(6):1908-1917. PubMed ID: 31939034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
    Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
    J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.
    Buettner S; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Weiss M; Fields RC; Krasnick B; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Koerkamp BG; Maithel SK; Pawlik TM
    J Gastrointest Surg; 2017 Nov; 21(11):1813-1820. PubMed ID: 28913712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
    Akazawa Y; Mizuno S; Fujinami N; Suzuki T; Yoshioka Y; Ochiya T; Nakamoto Y; Nakatsura T
    Sci Rep; 2019 Apr; 9(1):5925. PubMed ID: 30976046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer.
    Il Yu J; Chul Park H; Hoon Lim D; Oh Park J; Suk Park Y; Tae Kim S; Ho Choi S; Wook Choi D; Woong Han I; Seok Heo J
    Tumori; 2017 Jul; 103(4):345-352. PubMed ID: 28708225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
    Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Takeda T; Saito T; Mizuno S; Kogure H; Tada M; Koike K
    Invest New Drugs; 2018 Dec; 36(6):1093-1102. PubMed ID: 30324343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
    Vivaldi C; Fornaro L; Ugolini C; Niccoli C; Musettini G; Pecora I; Cacciato Insilla A; Salani F; Pasquini G; Catanese S; Lencioni M; Masi G; Campani D; Fontantini G; Falcone A; Vasile E
    Oncologist; 2020 Oct; 25(10):886-893. PubMed ID: 32353192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
    Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.
    Matsukuma S; Nagano H; Kobayashi S; Wada H; Seo S; Tsugawa D; Okuyama H; Iida K; Ohmura Y; Takeda Y; Miyamoto A; Nakashima S; Yamada T; Ajiki T; Tsuji A; Yoshimura K; Eguchi H; Hatano E; Ioka T;
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1323. PubMed ID: 33283475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
    Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
    Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
    Sebbagh S; Roux J; Dreyer C; Neuzillet C; de Gramont A; Orbegoso C; Hentic O; Hammel P; de Gramont A; Raymond E; André T; Chibaudel B; Faivre S
    Acta Oncol; 2016; 55(9-10):1168-1174. PubMed ID: 27333436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
    Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
    J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of initial disease recurrence after resection of biliary tract cancer.
    Jung SJ; Woo SM; Park HK; Lee WJ; Han MA; Han SS; Kim SH; Park SJ; Kim TH; Koh YH; Hong EK
    Oncology; 2012; 83(2):83-90. PubMed ID: 22777276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
    Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
    Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.